Day: September 25, 2020

MIDLAND, Tx., Sept. 25, 2020 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release third quarter 2020 financial results on November 2, 2020 after the market closes.In connection with the earnings release, Diamondback will host a conference call and webcast for investors and analysts to discuss its results for the third quarter of 2020 on Tuesday, November 3, 2020 at 8:00 a.m. CT. Participants should call (877) 440-7573 (United States/Canada) or (253) 237-1144 (International) and use the confirmation code 2493666. A telephonic replay will be available from 11:00 a.m. CT on Tuesday, November 3, 2020, through Tuesday, November 10, 2020 at 11:00 a.m. CT. To access the replay, call (855) 859-2056 (United States/Canada) or (404) 537-3406 (International) and enter confirmation...

MIDLAND, Texas, Sept. 25, 2020 (GLOBE NEWSWIRE) — Viper Energy Partners LP (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release third quarter 2020 financial results on November 2, 2020 after the market closes.In connection with the earnings release, Viper will host a conference call and webcast for investors and analysts to discuss its results for the third quarter of 2020 on Tuesday, November 3, 2020 at 10:00 a.m. CT. Participants should call (844) 400-1537 (United States/Canada) or (703) 326-5198 (International) and use the confirmation code 3361815. A telephonic replay will be available from 1:00 p.m. CT on Tuesday, November 3, 2020, through Tuesday, November 10, 2020 at 1:00 p.m. CT. To access the replay, call (855) 859-2056 (United States/Canada)...

– Brown Advisory, Greenhouse Funds and TT Investimentos to Participate in an Offering of Common Stock Expected to Provide Greater Optionality in Evaluating Market Opportunities and Facilitate Future Growth ‐SALT LAKE CITY, Sept. 25, 2020 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a company focused on the outdoor and consumer industries, announced today that it has entered into an agreement with three of its top 10 investors (the “Investors”) for the sale of 900,000 registered shares of the Company’s common stock at $12.75 for total proceeds of approximately $11.5 million.The Investors—Brown Advisory, Greenhouse Funds and TT Investimentos— have each determined to increase their investment in recognition of management’s past execution and in support of the Company’s long‐term growth...

Lima, Sept. 25, 2020 (GLOBE NEWSWIRE) — Lima, PERU, September 25, 2020 — Credicorp (NYSE: BAP) invites institutional investors and sell-side analysts to participate in its virtual Investor Day, commemorating Credicorp’s 25th Anniversary of its listing in the New York Stock Exchange. Presentations and a Q&A session will take place on October 1, 2020.Time:8:30 – 11:00 PET9:30 – 12:00 ET14:30 – 17:00 BTPresenters include:Mr. Luis Enrique Romero, Executive ChairmanMr. Walter Bayly, CEOMr. Gianfranco Ferrari, Deputy CEO and CEO of BCPMr. Javier Ichazo, Head of Microfinance and CEO of MibancoMr. Alvaro Correa, Deputy CEO, Head of Insurance & Pensions, IB &WMMr. Eduardo Montero, Head of IB & WMMr. Cesar Rios, CFOTo register for the event, please visit credicorpday.comPresentation materials and a webcast replay...

RESULTATS SEMESTRIELS 2020Paris, le 25 septembre 2020Patrimoine161,3 Millions d’euros (avant cession de l’immeuble Bizet post-clôture)Résultat net consolidé(Part du groupe)–  1 817 K€Actif net réévalué(Part du groupe)141 698 K€ANR par action au 30/06/20200,96 € / actionUn patrimoine immobilier de grande qualité évalué à 161,3 millions d’euros constitué d’immeubles de placements, uniquement en baisse de 1,2% par rapport au 31 décembre 2019 dans un contexte sanitaire difficile.Plus de 95% du patrimoine en valeur est localisé à Paris dans le QCA (Quartier Central des Affaires).Le patrimoine en valeur est essentiellement composé de surfaces de bureaux et de commerces, permettant d’offrir une rentabilité régulière dans une zone où la demande est importante.Cours du 25/09/20200,409 € / actionChiffres clés de l’activité(1)    Les intérêts...

– Fetal Hemoglobin expression in human cellular models increased up to ~30% by FTX-6058 for the potential treatment of sickle-cell disease– Company plans to initiate Phase 1 trial in healthy volunteers by year-end– Non-provisional composition of matter patent application covering FTX-6058 publishedCAMBRIDGE, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced preclinical proof-of-concept data supporting the development of FTX-6058 to treat sickle cell disease and beta-thalassemia. FTX-6058, a small molecule designed to increase expression of fetal hemoglobin, demonstrated target engagement and good tolerability in multiple preclinical rodent...

Amsterdam, September 25, 2020Press ReleaseHALF-YEAR RESULTS 2020: UNIBAIL-RODAMCO-WESTFIELD N.V.On September 25, 2020, Unibail-Rodamco-Westfield N.V. (“URW NV”) announced its 2020 half-year results and released its consolidated interim financial statements for the period ending June 30, 2020, which can be found on: https://www.urw-nv.com/en/investors/press-releases and as an attachment to this press release. URW NV and its consolidated entities, together with Unibail-Rodamco-Westfield SE (“URW SE”) and its consolidated entities, form Unibail-Rodamco-Westfield (“URW”). URW SE consolidates URW NV and its controlled undertakings, and its 2020 half-year results represent a comprehensive overview of URW, and is available on: https://www.urw.com/en/investors/financial-information/financial-resultsFor further information, please contact:Investor...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “Taat”) announces that the expiry date (the “Expiry Date”) for the warrants issued on August 28, 2020 and September 11, 2020 (the “Warrants”), with regard to its recent non-brokered private placement (see news releases dated August 28, 2020 and September 11, 2020), has been accelerated to 30 days from today’s date (for a new Expiry Date of October 25, 2020). The acceleration of the Expiry Date is due to a trigger event which occurred due to the closing price of the common shares being equal or greater than $1.25 for a period of five (5) consecutive trading days,...

 — Jyseleca®  Demonstrated Durable Efficacy Combined with a Consistent Safety Profile in Rheumatoid Arthritis Through 52 Weeks in Phase 3 Clinical Development Program —Foster City, Calif., & Mechelen, Belgium, September 25, 2020, 19.00 CET – Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced that the European Commission (EC) has granted marketing authorization for Jyseleca® (filgotinib 200 mg and 100 mg tablets), a once-daily, oral, JAK1 inhibitor for the treatment of adults with moderate to severe active rheumatoid arthritis (RA) who have responded inadequately to, or are intolerant to, one or more disease modifying anti-rheumatic drugs (DMARDs). Jyseleca may be used as monotherapy or in combination with methotrexate (MTX).1RA is a chronic, progressive, systemic, inflammatory...